Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis

Journal of Rheumatology

Volumn 25, Issue 7, 1998, Pages 1330-1335

  Lock, Guntram ^a,b   Straub, Rainer H ^a,b   Zeuner, Martin ^a,b   Antoniou, Erietta ^a,b   Holstege, Axel ^a,b   Schölmerich, Jürgen ^a,b   Lang, Bernhard ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Department of Medicine ^*

Author keywords

Autonomic function test; Autonomic neuropathy; Esophageal manometry; Scleroderma

Indexed keywords

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; ESOPHAGUS FUNCTION DISORDER; HUMAN; MANOMETRY; PATHOGENESIS; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS;

EID: 0031838205     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Poirier TJ, Rankin GB. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol 1972;58:30-44.
2. Orringer MB, Dabich L, Zarafonetis CJD, Sloan H. Gastroesophageal reflux in esophageal scleroderma: diagnosis and implications. Ann Thorac Surg 1976;22:120-30.
3. Zaninotto G, Peserico A, Costantini M, et al. Oesophageal motility and lower oesophageal sphincter competence in progressive systemic sclerosis and localized scleroderma. Scand J Gastroenterol 1989;24:95-102.
4. Treacy WL, Baggenstoss AH, Slocumb CH, Code CF. Scleroderma of the esophagus. A correlation of histologic and physiologic findings. Ann Intern Med 1963;59:351-6.
5. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). Am J Med 1969; 46:428-40.
6. Lock G, Holstege A, Lang B, Schölmerich J. Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 1997;92:763-71.
7. Cohen S, Fisher R, Lipshutz W, Turner R, Myers A, Schumacher R. The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease. J Clin Invest 1972;51:2663-8.
8. Schuffler MD, Beegle RG. Progressive systemic sclerosis of the gastrointestinal tract and hereditary hollow visceral myopathy: two distinguishable disorders of intestinal smooth muscle. Gastroenterology 1979;77:664-71.
9. Stevens MB, Hookman P, Siegel CI. Aperistalsis of the esophagus in patients with connective tissue disorders and Raynaud's phenomenon. N Engl J Med 1964;270:1218-22.
10. Belch JJ, Land D, Park RH, McKillop JH, MacKenzie JF. Decreased esophageal blood flow in patients with Raynaud's phenomenon. Br J Rheumatol 1988;27:426-30.
11. Howe S, Eaker EY, Sallustio JE, Peebles C, Tan EM, Williams RC. Antimyenteric neuronal antibodies in scleroderma. J Clin Invest 1994;94:761-70.
12. Sjogren RW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol 1996;8:569-75.
13. Hietaharju A, Jaaskelainen S, Kalimo H, Hietarinta M. Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma). Muscle Nerve 1993;16:1204-12.
14. Hietarinta M, Lassila O, Hietaharju A. Association of anti-U1 RNP and anti-SCL 70-antibodies with neurological manifestations in systemic sclerosis (scleroderma). Scand J Rheumatol 1994;23:64-7.
15. Suarez-Almazor ME, Bruera E, Russell AS. Normal cardiovascular autonomic function in patients with systemic sclerosis (CREST variant). Ann Rheum Dis 1988;47:672-4.
16. Dessein PH, Joffe BI, Metz RM, Millar DL, Lawson M, Stanwix AE. Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 1992;93:143-150.
17. Klimiuk PS, Taylor L, Baker RD, Jayson MI. Autonomic neuropathy in systemic sclerosis. Ann Rheum Dis 1988;47:542-5.
18. Sonnex C, Paice E, White AG. Autonomic neuropathy in systemic sclerosis: a case report and evaluation of six patients. Ann Rheum Dis 1986;45:957-60.
19. Hermosillo AG, Ortiz R, Dabagues J, Casanova JM, Martinez-Lavin M. Autonomic dysfunction in diffuse scleroderma vs CREST: an assessment by computerized heart rate variability. J Rheumatol 1994;21:1849-54.
20. Straub RH, Zeuner M, Lock G, et al. Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis. J Rheumatol 1996;23:87-92.
21. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-590.
22. 22; LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis [editorial]. J Rheumatol 1988;15:202-5.
23. Richter JE, Wu WC, Johns DN, et al. Esophageal manometry in 95 healthy adult volunteers. Dig Dis Sci 1987;35:583-92.
24. Ziegler D, Laux G, Dannehl K, et al. Assessment of cardiovascular autonomie function: age related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabetic Med 1992;9:166-75.
25. Weinberg CR, Pfeifer MA. An improved method for measuring heart-rate variability: assessment of cardiac autonomie function. Biometrics 1984;40:855-61.
26. Genovely H, Pfeifer MA. RR-variation: The autonomic test of choice in diabetes. Diab Metab Rev 1988;4:255-71.
27. Straub RH, Thies U, Jeron A, Palitzsch KD, Scholmerich J. Valid parameters for investigation of the pupillary light reflex in normal and diabetic subjects shown by factor analysis and partial correlation. Diabetologica 1994;37:414-9.
28. Straub RH, Thies U, Kerp L. The pupillary light reflex. 1. Age-dependent and age-independent parameters in normal subjects. Ophthalmologica 1992;204:134-42.
29. DiMarino AJ, Carlson G, Myers A, Schumacher HR, Cohen S. Duodenal myoelectric activity in scleroderma. N Engl J Med 1973;289:1220-3.
30. Greydanus MP, Camilleri M. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 1973;96:110-5.
31. Battle WM, Snape WJ, Wright S, et al. Abnormal colonic motility in progressive systemic sclerosis. Ann Intern Med 1981;94:749-52.
32. Kästenbauer T, Auinger M, Irsigler K. Prävalenz der kardialen autonomen Neuropathie bei Urämie und Diabetes mellitus. [Prevalence of cardioautonomic neuropathy in uremia and diabetes mellitus]. Wiener Klin Wschr 1994;106:733-7.
33. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491-8.
34. Hollis JB, Castell DO, Braddom RL. Esophageal function in diabetes mellitus and its relation to peripheral neuropathy. Gastroenterology 1977;73:1098-102.
35. Loo FD, Dodds WJ, Soergel KH, Arndorfer RC, Helm JF, Hogan WJ. Multipeaked esophageal peristaltic pressure waves in patients with diabetic neuropathy. Gastroenterology 1985;88:485-91.
36. Vannini P, Ciaravella A, Corbelli C, et al. Oesophageal transit time and cardiovascular autonomic neuropathy in type 1 diabetes mellitus. Diabetes Res 1989;11:21-5.
37. Rubinow A, Burakoff R, Cohen AS, Harris LD. Esophageal manometry in systemic amyloidosis. A study of 30 patients. Am J Med 1983;75:951-6.
38. Eckardt VF, Stenner F, Liewen H, Roder R, Koop H, Bernhard G. Autonomie dysfunction in patients with achalasia. Neurogastroenterol Motil 1995;7:55-61.
39. Cunningham KM, Horowitz M, Riddell PS, et al. Relations among autonomie nerve dysfunction, esophageal motility, and gastric emptying in gastro-esophageal reflux disease. Gut 1991;32:1436-40.